BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31383697)

  • 21. Prognostic Role of High Gal-9 Expression in Solid Tumours: a Meta-Analysis.
    Wang K; Chen Z; Wu R; Yin J; Fan M; Xu X
    Cell Physiol Biochem; 2018; 45(3):993-1002. PubMed ID: 29428936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
    Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
    BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA activated by TGF-β expression in cancer prognosis: A meta-analysis.
    Shen X; Piao L; Zhang S; Cui Y; Cui Y; Quan X; Sun H
    Int J Surg; 2018 Oct; 58():37-45. PubMed ID: 30121307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
    Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
    PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis.
    Li Y; Qin Y
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):545-553. PubMed ID: 32036456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis.
    Yu CP; Fu SF; Chen X; Ye J; Ye Y; Kong LD; Zhu Z
    Cell Physiol Biochem; 2018; 49(1):134-143. PubMed ID: 30134237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
    Chen C; Feng Y; Wang X
    Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of MiR-34a in solid tumors: a systemic review and meta-analysis with 4030 patients.
    Ren F; Zhang X; Liang H; Luo D; Rong M; Dang Y; Chen G
    Int J Clin Exp Med; 2015; 8(10):17377-91. PubMed ID: 26770329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
    Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
    Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and clinicopathological significance of LOXL2 in cancers: A systematic review and meta-analysis.
    Zhang X; Huang J; You F; Li W; Zou Z
    J Cell Physiol; 2019 Nov; 234(11):21369-21379. PubMed ID: 31032923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H
    Front Physiol; 2018; 9():452. PubMed ID: 29765332
    [No Abstract]   [Full Text] [Related]  

  • 33. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
    Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
    Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
    Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
    Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies.
    Yu M; Chen S; Hong W; Gu Y; Huang B; Lin Y; Zhou Y; Jin H; Deng Y; Tu L; Hou B; Jian Z
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):967-999. PubMed ID: 30825027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.
    Razmi M; Ghods R; Vafaei S; Sahlolbei M; Saeednejad Zanjani L; Madjd Z
    Cancer Cell Int; 2021 Feb; 21(1):139. PubMed ID: 33639931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Li C; Zuo D; Liu T; Yin L; Li C; Wang L
    Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and clinicopathological significance of Cks1 in cancer: Evidence from a meta-analysis.
    Zhang Y; Chen Y; You F; Li W; Lang Z; Zou Z
    J Cell Physiol; 2019 Aug; 234(8):13423-13430. PubMed ID: 30605238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies.
    Zhou Y; Chen S; Cheng S; Wei Q; Fathy AH; Shan T
    Clin Chim Acta; 2018 Jun; 481():147-153. PubMed ID: 29544748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
    Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
    Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.